Jaguar Health, Inc. (JAGX)
NASDAQ·Healthcare·Biotechnology
$8.76
-74.59%
Mkt Cap $14.97K
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$3.21
Range $3.21 – $3.21
Implied Upside
-63.3%
Consensus $3.21 vs current $8.76
NASDAQ·Healthcare·Biotechnology
$8.76
-74.59%
Mkt Cap $14.97K
No recent rating data.
Price Target (2 analysts)
$3.21
Range $3.21 – $3.21
-63.3%
Consensus $3.21 vs current $8.76